JPMorgan Chase & Co’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-33
| Closed | -$14 | – | 6708 |
|
|
2024
Q4 | $14 | Buy |
+33
| New | +$14 | ﹤0.01% | 6247 |
|
|
2024
Q3 | – | Sell |
-15
| Closed | -$80 | – | 6641 |
|
|
2024
Q2 | $80 | Buy |
+15
| New | +$80 | ﹤0.01% | 5910 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6204 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6051 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | -$9K | – | 6031 |
|
|
2021
Q4 | $9K | Sell |
4
-7
| -64% | -$15.8K | ﹤0.01% | 5457 |
|
|
2021
Q3 | $50K | Buy |
+11
| New | +$50K | ﹤0.01% | 4961 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | -$19K | – | 5157 |
|
|
2020
Q3 | $19K | Buy |
+3
| New | +$19K | ﹤0.01% | 4500 |
|
|
2019
Q4 | – | Hold |
0
| – | -$5K | – | 4910 |
|
|
2019
Q3 | – | Sell |
-146
| Closed | -$1.15M | – | 4640 |
|
|
2019
Q2 | $1.15M | Buy |
146
+144
| +7,200% | +$1.13M | ﹤0.01% | 2983 |
|
|
2019
Q1 | $25K | Sell |
2
-20
| -91% | -$250K | ﹤0.01% | 4451 |
|
|
2018
Q4 | $328K | Sell |
22
-28
| -56% | -$417K | ﹤0.01% | 3578 |
|
|
2018
Q3 | $1.87M | Sell |
50
-73
| -59% | -$2.73M | ﹤0.01% | 2820 |
|
|
2018
Q2 | $4.75M | Buy |
123
+96
| +356% | +$3.7M | ﹤0.01% | 2272 |
|
|
2018
Q1 | $891K | Buy |
+27
| New | +$891K | ﹤0.01% | 3140 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4530 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$20K | – | 4295 |
|
|
2016
Q2 | $20K | Hold |
1
| – | – | ﹤0.01% | 3714 |
|
|
2016
Q1 | $30K | Buy |
+1
| New | +$30K | ﹤0.01% | 3524 |
|